Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Dexin Ren Sheng Pharmaceutical is a China-based company primarily focused on the distribution, wholesale, and retail of pharmaceutical and healthcare products. Established in 2013, the company operates as a regional player in the Shandong province, supplying a wide range of chemical drugs, traditional Chinese medicines, and medical devices to hospitals and clinics. It maintains an extensive network of retail pharmacies and specialized logistics services to support the pharmaceutical supply chain. While the company does not engage in proprietary drug discovery or biotechnology R&D, it plays a vital role in the commercialization and accessibility of medicines in its target region. The business is characterized by its strong logistical infrastructure and focus on the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Dexin Ren Sheng Pharmaceutical.